The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors
NCT ID: NCT02510430
Last Updated: 2018-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2015-11-30
2018-01-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin
NCT02677389
Physical Activity and Nutrition in Cancer Survivors
NCT06350214
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors
NCT05012176
Developing a Healthy Lifestyle in Breast Cancer Survivors
NCT02677857
Optimizing Functional Recovery of Breast Cancer Survivors
NCT03915548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reducing Sitting Time Group
This group will be asked to reduce overall accumulated sitting time by 2 hours per day.
Reducing Sitting Time Group
This is a behavioral intervention to help women reduce their overall accumulated sitting time by 2 hours per day.
Re-Patterning Sitting Time Group
This group will be asked to use standing breaks to interrupt long bouts of sitting time.
Re-Patterning Sitting Time Group
This is a behavioral intervention to help women interrupt long bouts of sitting time by incorporating standing breaks into their lifestyle.
Usual Care
This is an attention control group and is not asked to make changes to sitting time.
Usual Care
This intervention consists solely of follow-up contact to control for attention effects and reduce attrition.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Re-Patterning Sitting Time Group
This is a behavioral intervention to help women interrupt long bouts of sitting time by incorporating standing breaks into their lifestyle.
Reducing Sitting Time Group
This is a behavioral intervention to help women reduce their overall accumulated sitting time by 2 hours per day.
Usual Care
This intervention consists solely of follow-up contact to control for attention effects and reduce attrition.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Completed primary treatment defined as definitive surgery, (neo)adjuvant chemotherapy and/or (neo)adjuvant radiation. Participants still receiving adjuvant endocrine or HER2 targeted therapies are eligible.
3. Report sitting for ≥8 accumulated waking hours on a typical day,
4. Willing and able to attend 3 study visits at the UW,
5. Willing to attempt reduction of sitting time,
6. Use the internet on a regular basis,
7. Willing and able to complete study requirements, and
8. Currently considered postmenopausal (no menstrual periods in past 12 months), even if pre-menopausal at diagnosis.
Exclusion Criteria
2. Unable to move from sitting to standing without difficulty and to walk 1 block.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Wisconsin, Madison
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa A Cadmus-Bertram, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UW Hospital
Madison, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UW14101
Identifier Type: OTHER
Identifier Source: secondary_id
2015-0449
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.